Literature DB >> 24509184

Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.

Maarten G Thomeer1, Mirelle E E Bröker, Quido de Lussanet, Katharina Biermann, Roy S Dwarkasing, Rob de Man, Jan N Ijzermans, Marianne de Vries.   

Abstract

Hepatocellular adenoma (HCA) is a generally benign liver tumor with the potential for malignancy and bleeding. HCAs are categorized into four subtypes on the basis of genetic and pathological features: hepatocyte nuclear factor 1α-mutated HCA, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA. Magnetic resonance imaging (MRI) plays an important role in the diagnosis, subtype characterization, and detection of HCA complications; it is also used to differentiate HCA from focal nodular hyperplasia. In this review, we present an overview of the genetic abnormalities, oncogenesis, and typical and atypical MRI findings of specific subtypes of HCA using contrast-enhanced MRI with or without hepatobiliary contrast agents (gadobenate dimeglumine and gadoxetate disodium). We also discuss their different management implications after diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509184      PMCID: PMC4463344          DOI: 10.5152/dir.2013.13315

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  39 in total

Review 1.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

Review 2.  Approach to a liver mass.

Authors:  K R Reddy; E R Schiff
Journal:  Semin Liver Dis       Date:  1993-11       Impact factor: 6.115

3.  Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification.

Authors:  Maxime Ronot; Stephane Bahrami; Julien Calderaro; Dominique-Charles Valla; Pierre Bedossa; Jacques Belghiti; Jacques Belghti; Valérie Vilgrain; Valérie Paradis
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.

Authors:  Hervé Laumonier; Hélène Cailliez; Charles Balabaud; Laurent Possenti; Jessica Zucman-Rossi; Paulette Bioulac-Sage; Hervé Trillaud
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

5.  Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.

Authors:  Paulette Bioulac-Sage; Sandra Rebouissou; Antonio Sa Cunha; Emmanuelle Jeannot; Sébastien Lepreux; Jean-Frédéric Blanc; Hélène Blanché; Brigitte Le Bail; Jean Saric; Pierre Laurent-Puig; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

6.  Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.

Authors:  Susanna M van Aalten; Joanne Verheij; Turkan Terkivatan; Roy S Dwarkasing; Robert A de Man; Jan N M Ijzermans
Journal:  J Hepatol       Date:  2010-11-24       Impact factor: 25.083

7.  Hepatocellular adenomas in men: MRI findings in four patients.

Authors:  Evlampia A Psatha; Richard C Semelka; Diane Armao; John T Woosley; Zeynep Firat; Guenther Schneider
Journal:  J Magn Reson Imaging       Date:  2005-08       Impact factor: 4.813

8.  Hepatic adenomata with type 1 glycogen storage disease.

Authors:  R R Howell; R E Stevenson; Y Ben-Menachem; R L Phyliky; D H Berry
Journal:  JAMA       Date:  1976-09-27       Impact factor: 56.272

9.  Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use.

Authors:  H Bühler; M Pirovino; A Akobiantz; J Altorfer; M Weitzel; E Maranta; M Schmid
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

10.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

View more
  6 in total

1.  Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.

Authors:  Edouard Reizine; Maxime Ronot; Frederic Pigneur; Yvonne Purcell; Sebastien Mulé; Marco Dioguardi Burgio; Julien Calderaro; Giuliana Amaddeo; Alexis Laurent; Valérie Vilgrain; Alain Luciani
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 2.  Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.

Authors:  Marco Di Pietropaolo; Chiara Briani; Emanuela Pilozzi; Francesco Carbonetti; Vincenzo David; Elsa Iannicelli
Journal:  J Gastrointest Cancer       Date:  2015-12

3.  Imaging of aberrant left gastric vein and associated pseudolesions of segments II and III of the liver and mimickers.

Authors:  Emre Unal; Mustafa Nasuh Ozmen; Deniz Akata; Musturay Karcaaltincaba
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 4.  Hepatocellular adenoma: when and how to treat? Update of current evidence.

Authors:  Maarten G Thomeer; Mirelle Broker; Joanne Verheij; Michael Doukas; Turkan Terkivatan; Diederick Bijdevaate; Robert A De Man; Adriaan Moelker; Jan N IJzermans
Journal:  Therap Adv Gastroenterol       Date:  2016-09-28       Impact factor: 4.409

Review 5.  Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.

Authors:  Yongfei Guo; Wenjuan Li; Wenli Cai; Yi Zhang; Yijie Fang; Guobin Hong
Journal:  Int J Med Sci       Date:  2017-06-23       Impact factor: 3.738

6.  Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis.

Authors:  Yongfei Guo; Wenjuan Li; Zhinan Xie; Yi Zhang; Yijie Fang; Wenli Cai; Guobin Hong
Journal:  J Cancer       Date:  2017-05-11       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.